FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

838468009: Enfortumab vedotin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3897068011 Enfortumab vedotin (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3897069015 Enfortumab vedotin en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Enfortumab vedotin Has disposition Microtubule inhibitor true Inferred relationship Existential restriction modifier
Enfortumab vedotin Is a Substance with microtubule inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Enfortumab vedotin Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Enfortumab vedotin Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Enfortumab vedotin Has active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier 1
Product containing enfortumab vedotin in parenteral dose form (medicinal product form) Has active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier 1
Product containing enfortumab vedotin (medicinal product) Has active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier 1
Product containing only enfortumab vedotin in parenteral dose form (medicinal product form) Has active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier 1
Enfortumab vedotin 20mg powder for solution for infusion vials Has specific active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier
Enfortumab vedotin 30mg powder for solution for infusion vials Has specific active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier
Enfortumab vedotin 30mg powder for solution for infusion vials 1 vial Has specific active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has specific active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) 1 vial Has specific active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier
Enfortumab vedotin 20mg powder for solution for infusion vials 1 vial Has specific active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier
Padcev 20mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) 1 vial Has specific active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier
Padcev 20mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has specific active ingredient True Enfortumab vedotin Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start